Related Experiment Video
Updated: May 21, 2026

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
[Effects of MSCs on the progression of atherosclerosis plaque in ApoE-knock out mice]
Zhi-xiao Wang1, Shan Mao, Yu Li
1Department of Cardiology, Hubei University of Medicine, Shiyan, China.
Aim:
To explore the effects of mesenchymal stem cells in the formation of atherosclerosis plaque in hypercholesterolemic apoliprotein (apo) E -/ - mice. METH-ODS: ApoE -- mice mesenchymal stem cells (MSCs)were isolated and identified. Thirty ApoE -/ - mice were divided into negative control group (Neg, n = 10), positive control group (Pos, n = 10) and MSCs group ( n = 10).MSCs were injected through caudal vein into the body ofPos and MSCs groups. The plaque area of all subjects were compared, the percentage of CD4 CD25' regulatory T cells in different tissues were analyzed by FACS, proliferation response of splenocytes to mesenchymal stem cells and cyto-kines in the supernatant were determined by ELISA. RE-SULTS: Compared with controls, MSCs resulted in a significant decrease of the atherosclerotic plaques size (P <0.05), and a significant increase of CD4 CD25 regulatory T cells in spleen (P<0.05). Specific proliferation response of CD4' CD25' regulatory T cells in splenocytes to MSCswas significantly suppressed. The supernatant levels ofTGF-f3 and IL-10 in MSCs group were increased while IFN-y decreased significantly.
Conclusion:
MSCs play an important role in regulating the inflammatory response and may significantly inhibit the formation of the atherosclerosis plaque in ApoE-'- mice.
Insights
Mesenchymal stem cells (MSCs) significantly reduced atherosclerosis plaque size in mice. MSCs also modulated immune responses, increasing regulatory T cells and anti-inflammatory cytokines, suggesting a therapeutic role in atherosclerosis.
Area of Science:
- Immunology
- Cardiovascular Research
- Regenerative Medicine
Background:
- Atherosclerosis is a chronic inflammatory disease.
- Hypercholesterolemia accelerates atherosclerosis plaque formation.
- Mesenchymal stem cells (MSCs) possess immunomodulatory properties.
Purpose of the Study:
- To investigate the therapeutic potential of MSCs in inhibiting atherosclerosis.
- To analyze the impact of MSCs on plaque size and immune cell populations in hypercholesterolemic mice.
Main Methods:
- Atherosclerosis was induced in apolipoprotein E knockout (ApoE-/-) mice.
- Mesenchymal stem cells (MSCs) were administered intravenously.
- Atherosclerotic plaque area, regulatory T cell (Treg) percentages, splenocyte proliferation, and cytokine levels were assessed.
Main Results:
- MSC treatment significantly reduced atherosclerotic plaque size compared to controls.
- MSC administration increased the percentage of CD4+CD25+ regulatory T cells in the spleen.
- MSCs modulated cytokine profiles, increasing TGF-β and IL-10, and decreasing IFN-γ.
Conclusions:
- MSCs play a crucial role in regulating inflammatory responses.
- MSC therapy demonstrates significant potential in inhibiting atherosclerosis plaque formation in ApoE-/- mice.
More Related Videos
Related Concept Videos
Atherosclerosis I: Introduction
Atherosclerosis III: Management
